Submandibular Gland Preservation in Neck Dissection

Status Recruiting

Clinical Trial Summary

Trial design: a randomized controlled trial. Eligibility criteria for participants: patients with primary early stage oral squamous cell carcinoma. Exclusion criteria: cancer of the floor of the mouth. Interventions: submandibular gland is preserved during neck dissection for patients of the experimental group; submandibular gland is removed during neck dissection for patients of the control group. Primary Parameters: survival rate, mortality rate

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03385720
Study type	Interventional
Source	Peking University
Contact	Jia-Zeng Su, Dr.
Phone	86 10 82195992
Email	sujiazeng@163.com
Status	Recruiting
Phase	N/A
Start date	December 5, 2017
Completion date	December 2030

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06031337` - Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study
Completed	`NCT00158678` - IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC	Phase 3
Completed	`NCT00933387` - A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma	Phase 2
Enrolling by invitation	`NCT05030597` - Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma	N/A
Completed	`NCT03682562` - Diagnostic Accuracy of Salivary DNA Integrity Index in Oral Malignant and Premalignant Lesions
Recruiting	`NCT03684707` - Cancer Chemoprevention by Metformin Hydrochloride Compared to Placebo in Oral Potentially Malignant Lesions	Phase 4
Recruiting	`NCT06130332` - Neoadjuvant Tirellizumab Combined With Chemotherapy for Early Oral Squamous Cell Carcinoma(HNC-SYSU-004)	Phase 2
Recruiting	`NCT04372914` - Prevention of Oral DNA Damage by Black Raspberries	N/A
Active, not recruiting	`NCT03529422` - Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN	Phase 2
Recruiting	`NCT03686020` - Sensitivity and Specificity of Serum and Salivary CYFRA21-1 in the Detection of Malignant Transformation in Oral Potentially Malignant Mucosal Lesions (Diagnostic Accuracy Study)
Not yet recruiting	`NCT06060288` - Diagnostic Accuracy of Mobile Phone Imaging Compared to Conventional Clinical Examination for Oral Cancer Screening
Withdrawn	`NCT00951470` - Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema	N/A
Completed	`NCT00964977` - Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.	Phase 3
Completed	`NCT01418118` - Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery	Phase 4
Active, not recruiting	`NCT00232960` - Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC	N/A
Recruiting	`NCT05429099` - Mandibular Reconstruction Preplanning (ViPMR)	Phase 2/Phase 3
Completed	`NCT04614896` - Use of Ultrasound for Measuring Size of Oral Tongue Cancers	N/A
Recruiting	`NCT03685409` - Cancer Chemoprevention by Metformin Hydrochloride in Oral Potentially Malignant Lesions	Phase 3
Completed	`NCT00402779` - Erlotinib Prevention of Oral Cancer (EPOC)	Phase 3
Recruiting	`NCT05153733` - Improved Implant for Reconstruction Purposes After Mandibular Resection	N/A